MedPath

Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia

Not Applicable
Conditions
Pre-Eclampsia
Registration Number
NCT03630276
Lead Sponsor
Ain Shams University
Brief Summary

Evaluation of neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP as markers of severity of Pre-eclampsia

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
111
Inclusion Criteria
  • PREECLAMPSIA from 25_45years
Exclusion Criteria
  • chronic diseases Primary hypertension

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
PREECLAMPSIA6months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shaza

🇪🇬

Alexandria, Alex, Egypt

Shaza
🇪🇬Alexandria, Alex, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.